Proposed design of a dissolution apparatus for vaginal formulations containing probiotics

Dissolution Technologies

Volumn 15, Issue 2, 2008, Pages 27-29

  Kale, Vinita ^a   Trivedi, Rashmi ^a   Muley, Pratik ^a  

^a Nagar Yuwak Shikshan Sanstha   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CITRIC ACID; LACTOSE; PROBIOTIC AGENT;

APPARATUS; ARTICLE; DISSOLUTION; DRUG DESIGN; DRUG STABILITY; IN VIVO STUDY; INTRAVAGINAL DRUG ADMINISTRATION; LACTOBACILLUS; LYOPHILISATE; QUALITY CONTROL; SURFACE PROPERTY; TABLET FORMULATION;

EID: 58849144982     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT150208P27     Document Type: Article

References (13)

1. Siewert, M.; Dressman, J.; Brown, C. K.; Shah, V. P. FIP/ AAPS Guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 2003, 4 (1), Article 7.
2. Ritter, W.; Patzschke, K.; Krause, U.; Stettendorf, S. Pharmacokinetic fundamentals of vaginal treatment with clotrimazole. Chemotherapy 1982, 28 (Suppl. 1), 37-42.
3. Deshpande, A. A.; Rhodes, C. T.; Danish, M. Intravaginal drug delivery. Drug Dev. Ind. Pharm. 1992, 18, 1225-1279.
4. Hallen, A.; Pahlson, C. Treatment of bacterial vaginosis with lactobacilli. Sex Trans. Dis. 1992, 19, 146-148.
5. Reid, G. Probiotics for urogenital health. Nutr. Clin. Care. 2002, 5 (1), 3-8.
6. Ceschel, G. C; Maffei, P.; Lambardi Borgia, S.; Ronchi, C.; Rossi, S. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev. Ind. Pharm. 2001, 27 (6), 541-547.
7. Setnikar, I.; Fantelli, S. Liquefaction time of rectal suppositories. J. Pharm. Sci. 1962, 51 (6), 566-571.
8. Kale, V.; Dabre, R.; Bhusari, K. A new approach to the formulation of lactobacilli used as probiotic and anti diarrheal agent. Indian Drugs 1998, 35 (5), 281-285.
9. Nowroozi, J.; Mirzaii, M. Study of lactobacillus as pro biotic bacteria. Iranian J. Pub. Health 2004, 33 (22), 1-7.
10. Ceschel, G. C.; Rossi, S. Development of mucoadhesive dosage form for vaginal administration. Drug Dev. Ind. Phar. 2001, 27 (6), 541-547.
11. Pandit, J. K.; Choudhary, P. K.; Mishra, B. Modified bead-bed continuous flow dissolution apparatus for in vitro evaluation of suppository. Indian Pharmacist 1982, 32 (5), 132-134.
12. Babar, A.; Bellete, T.; Pakogiannis, F. M. Ketoprofen suppository dosage forms: In vitro release and in vivo absorption studies in rabbits. Drug Dev. Ind. Pharm. 1999, 25 (2), 241-245.
13. Azechi, Y.; Ishikawa, K.; Takahashi, K. Sustained release of diclofenac from polymer containing suppository and mechanism involved. Drug. Dev. Ind. Pharm. 2000, 26 (11), 1177-1183.